ID KPYM_PONAB Reviewed; 531 AA. AC Q5NVN0; Q5R500; DT 24-JAN-2006, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 3. DT 13-SEP-2023, entry version 112. DE RecName: Full=Pyruvate kinase PKM; DE EC=2.7.1.40 {ECO:0000250|UniProtKB:P14618}; DE AltName: Full=Pyruvate kinase muscle isozyme; GN Name=PKM; Synonyms=PKM2; OS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Pongo. OX NCBI_TaxID=9601; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain cortex; RG The German cDNA consortium; RL Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Catalyzes the final rate-limiting step of glycolysis by CC mediating the transfer of a phosphoryl group from phosphoenolpyruvate CC (PEP) to ADP, generating ATP. The ratio between the highly active CC tetrameric form and nearly inactive dimeric form determines whether CC glucose carbons are channeled to biosynthetic processes or used for CC glycolytic ATP production. The transition between the 2 forms CC contributes to the control of glycolysis and is important for tumor CC cell proliferation and survival. {ECO:0000250|UniProtKB:P14618}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + pyruvate = ADP + H(+) + phosphoenolpyruvate; CC Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216; CC EC=2.7.1.40; Evidence={ECO:0000250|UniProtKB:P14618}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:P14618}; CC -!- COFACTOR: CC Name=K(+); Xref=ChEBI:CHEBI:29103; CC Evidence={ECO:0000250|UniProtKB:P14618}; CC -!- ACTIVITY REGULATION: Has high pyruvate kinase activity by itself and CC does not require allosteric activation by D-fructose 1,6-bisphosphate CC (FBP) for activity. {ECO:0000250|UniProtKB:P14618}. CC -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D- CC glyceraldehyde 3-phosphate: step 5/5. {ECO:0000250|UniProtKB:P14618}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P14618}. CC -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P14618}. CC -!- PTM: Under hypoxia, hydroxylated by EGLN3. CC {ECO:0000250|UniProtKB:P14618}. CC -!- PTM: Acetylation at Lys-305 is stimulated by high glucose CC concentration, it decreases enzyme activity and promotes its lysosomal- CC dependent degradation via chaperone-mediated autophagy. CC {ECO:0000250|UniProtKB:P14618}. CC -!- PTM: FGFR1-dependent tyrosine phosphorylation is reduced by interaction CC with TRIM35. {ECO:0000250|UniProtKB:P14618}. CC -!- MISCELLANEOUS: There are 4 isozymes of pyruvate kinase in mammals (L, CC R, M1, M2) encoded by 2 different genes: PKLR and PKM. The L and R CC isozymes are generated from the PKLR by differential splicing of RNA; CC the M1 and M2 forms are produced from the PKM gene by differential CC splicing. L type is major isozyme in the liver, R is found in red CC cells, M1 is the main form in muscle, heart and brain, and M2 is found CC in early fetal tissues as well as in most cancer cells. CC {ECO:0000250|UniProtKB:P14618}. CC -!- SIMILARITY: Belongs to the pyruvate kinase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CR861086; CAH93166.1; -; mRNA. DR EMBL; CR925988; CAI29633.1; -; mRNA. DR RefSeq; NP_001127083.1; NM_001133611.1. DR AlphaFoldDB; Q5NVN0; -. DR SMR; Q5NVN0; -. DR STRING; 9601.ENSPPYP00000007498; -. DR GeneID; 100174114; -. DR KEGG; pon:100174114; -. DR CTD; 5315; -. DR eggNOG; KOG2323; Eukaryota. DR InParanoid; Q5NVN0; -. DR OrthoDB; 312683at2759; -. DR UniPathway; UPA00109; UER00188. DR Proteomes; UP000001595; Unplaced. DR GO; GO:0005791; C:rough endoplasmic reticulum; ISS:UniProtKB. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW. DR GO; GO:0000287; F:magnesium ion binding; IEA:InterPro. DR GO; GO:0003729; F:mRNA binding; ISS:UniProtKB. DR GO; GO:0030955; F:potassium ion binding; IEA:InterPro. DR GO; GO:0004743; F:pyruvate kinase activity; IEA:UniProtKB-EC. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:2000767; P:positive regulation of cytoplasmic translation; ISS:UniProtKB. DR GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISS:UniProtKB. DR CDD; cd00288; Pyruvate_Kinase; 1. DR Gene3D; 3.20.20.60; Phosphoenolpyruvate-binding domains; 1. DR Gene3D; 2.40.33.10; PK beta-barrel domain-like; 1. DR Gene3D; 3.40.1380.20; Pyruvate kinase, C-terminal domain; 2. DR InterPro; IPR001697; Pyr_Knase. DR InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom. DR InterPro; IPR040442; Pyrv_Kinase-like_dom_sf. DR InterPro; IPR011037; Pyrv_Knase-like_insert_dom_sf. DR InterPro; IPR018209; Pyrv_Knase_AS. DR InterPro; IPR015793; Pyrv_Knase_brl. DR InterPro; IPR015795; Pyrv_Knase_C. DR InterPro; IPR036918; Pyrv_Knase_C_sf. DR InterPro; IPR015806; Pyrv_Knase_insert_dom_sf. DR NCBIfam; TIGR01064; pyruv_kin; 1. DR PANTHER; PTHR11817; PYRUVATE KINASE; 1. DR PANTHER; PTHR11817:SF101; PYRUVATE KINASE PKM; 1. DR Pfam; PF00224; PK; 1. DR Pfam; PF02887; PK_C; 1. DR PRINTS; PR01050; PYRUVTKNASE. DR SUPFAM; SSF51621; Phosphoenolpyruvate/pyruvate domain; 1. DR SUPFAM; SSF50800; PK beta-barrel domain-like; 1. DR SUPFAM; SSF52935; PK C-terminal domain-like; 1. DR PROSITE; PS00110; PYRUVATE_KINASE; 1. PE 2: Evidence at transcript level; KW Acetylation; Allosteric enzyme; ATP-binding; Cytoplasm; Glycolysis; KW Isopeptide bond; Kinase; Magnesium; Metal-binding; Methylation; KW Nucleotide-binding; Phosphoprotein; Potassium; Pyruvate; KW Reference proteome; Transferase; Translation regulation; Ubl conjugation. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P11979" FT CHAIN 2..531 FT /note="Pyruvate kinase PKM" FT /id="PRO_0000112090" FT REGION 307..531 FT /note="Interaction with POU5F1" FT /evidence="ECO:0000250|UniProtKB:P14618" FT REGION 389..433 FT /note="Intersubunit contact" FT BINDING 70 FT /ligand="L-serine" FT /ligand_id="ChEBI:CHEBI:33384" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 73 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:P30613" FT BINDING 75..78 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 75 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 77 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 106 FT /ligand="L-serine" FT /ligand_id="ChEBI:CHEBI:33384" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 113 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 114 FT /ligand="K(+)" FT /ligand_id="ChEBI:CHEBI:29103" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 120 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 207 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 270 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:P30613" FT BINDING 272 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 295 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:P30613" FT BINDING 296 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 296 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:P30613" FT BINDING 328 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:P30613" FT BINDING 432..437 FT /ligand="beta-D-fructose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:32966" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 464 FT /ligand="L-serine" FT /ligand_id="ChEBI:CHEBI:33384" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 482 FT /ligand="beta-D-fructose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:32966" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 489 FT /ligand="beta-D-fructose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:32966" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:P14618" FT BINDING 516..521 FT /ligand="beta-D-fructose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:32966" FT /ligand_note="allosteric activator" FT /evidence="ECO:0000250|UniProtKB:P14618" FT SITE 270 FT /note="Transition state stabilizer" FT /evidence="ECO:0000250|UniProtKB:P00549" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000250|UniProtKB:P11979" FT MOD_RES 3 FT /note="N6,N6,N6-trimethyllysine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 37 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 41 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 62 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 66 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 89 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 97 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11980" FT MOD_RES 100 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P11980" FT MOD_RES 105 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 127 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 148 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 166 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 166 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 175 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 195 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 266 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 270 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 305 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P14618" FT MOD_RES 322 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 322 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 475 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P52480" FT MOD_RES 498 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P52480" FT CROSSLNK 115 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:P14618" FT CROSSLNK 166 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO1); alternate" FT /evidence="ECO:0000250|UniProtKB:P14618" FT CROSSLNK 266 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0000250|UniProtKB:P14618" FT CROSSLNK 270 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2); alternate" FT /evidence="ECO:0000250|UniProtKB:P14618" FT CONFLICT 153 FT /note="D -> G (in Ref. 1; CAH93166)" FT /evidence="ECO:0000305" FT CONFLICT 329 FT /note="Q -> R (in Ref. 1; CAH93166)" FT /evidence="ECO:0000305" FT CONFLICT 347 FT /note="G -> D (in Ref. 1; CAH93166)" FT /evidence="ECO:0000305" SQ SEQUENCE 531 AA; 58018 MW; 86BDD4AEF68B5510 CRC64; MSKPHSEAGT AFIQTQQLHA AMADTFLEHM CRLDIDSPPI TARNTGIICT IGPASRSVET LKEMIKSGMN VARLNFSHGT HEYHAETIKN VRTATESFAS DPILYRPVAV ALDTKGPEIR TGLIKGSGTA EVELKKGATL KITLDNAYME KCDENILWLD YKNICKVVEV GSKIYVDDGL ISLQVKQKGA DFLLTEVENG GSLGSKKGVN LPGAAVDLPA VSEKDIQDLK FGVEQDVDMV FASFIRKASD VHEVRKVLGE KGKNIKIISK IENHEGVRRF DEILEASDGI MVARGDLGIE IPAEKVFLAQ KMMIGRCNRA GKPVICATQM LESMIKKPRP TRAEGSGVAN AVLDGADCIM LSGETAKGDY PLEAVRMQHL IAREAEAAMF HRKLFEELVR ASSHSTDLME AMAMGSVEAS YKCLAAALIV LTESGRSAHQ VARYRPRAPI IAVTRNPQTA RQAHLYRGIF PVLCKDPVQE AWAEDVDLRV NFAMNVGKAR GFFKKGDVVI VLTGWRPGSG FTNTMRVVPV P //